Dr. Gerald Soff (IMAGE)
Caption
“CIT doesn’t just complicate treatment. It compromises it,” said Gerald Soff, M.D., chief of classical hematology at Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine. “When we reduce chemotherapy dose intensity, we may be giving cancer more opportunity to adapt and persist.”
Credit
Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content